Brian Nichols is the co-founder of Angel Squad, a community where you’ll learn how to angel invest and get a chance to invest as little as $1k into Hustle Fund's top performing early-stage startups

Deel did something most companies never manage: it went from roughly $290 million in revenue in 2022 to about $1.3 billion in 2025. That is real, fast, durable growth in a category, global hiring and payroll, that enterprises genuinely need. And yet, as of mid-2026, its secondary shares trade below the price of its last primary round.

Here's the tension. Deel is a clear category leader with strong revenue and a recent up round at $17.3 billion. But the secondary market is pricing it at a discount to that mark, with more sellers than buyers, which is the kind of signal worth understanding before you assume a below-round price means a bargain. Whether Deel is a good investment depends far less on whether the business is good and far more on the share class you buy, the price against the preference stack, and why the discount exists.

This guide is built for the accredited investor assessing private-market exposure, not retail buyers waiting for a ticker symbol. You'll learn how pre-IPO shares actually work, what the numbers say, and the risks that matter most.

What Deel Pre-IPO Shares Are (and What They Are Not)

Pre-IPO shares in a private company are usually existing shares sold by an employee, founder, or early investor in a secondary transaction. They are not publicly traded equity, and they do not come with continuous market pricing, broad SEC reporting, or automatic liquidity.

The distinction between a primary round and a secondary matters. A primary round creates new shares issued by the company and adds cash to the balance sheet. A secondary sale transfers ownership between private parties without funding company operations. Primary rounds often reset valuation benchmarks and rights packages. Secondaries usually reflect liquidity needs, bargaining power, and information gaps.

Deel allows direct stock transfers, which makes it more accessible than names that permit only indirect exposure. But accessibility cuts both ways: per Notice.co, investor demand is currently less than the supply of shares available, so a buyer has leverage on price while a holder looking to exit may have to accept a discount.

What is the Current Valuation of Deel?

Deel's last primary valuation is $17.3 billion, set in a $649.9 million Series E round that closed in October 2025 at roughly $38.92 per share, with investors including Coatue, Green Bay Ventures, and General Catalyst. That was a meaningful step up from the $12 billion mark it carried in 2024.

The secondary market sits below that. As of early June 2026, Notice.co marks Deel around $32.27 per share, an implied market capitalization near $14.32 billion, which it flags as roughly 17% below the last round valuation. The price has also been volatile: Deel traded around $24 through mid-2025, spiked to about $37.58 in the fourth quarter of 2025 around the Series E, then fell about 26% in the first quarter of 2026 to roughly $28 before recovering toward $32. So the headline is a company whose secondary price is both below its last round and bouncing around in a wide band.

Notice.co and Sacra-style estimates broadly agree on the shape here, a roughly $17.3 billion last round against a low-to-mid-$14 billion implied secondary cap, so the discount is not a single-source quirk. What it means is the open question, and the answer lives in the terms, not the headline.

At its simplest, Deel is software and services to hire and pay workers across many countries. It handles employer-of-record hiring, contractor management, global payroll, and local tax and labor compliance, and layers on benefits, equity and expense tools, and immigration support in some markets. The pitch is one platform for the messy, jurisdiction-by-jurisdiction problem of employing people globally.

How Does Deel Generate Revenue?

Deel generates revenue from its global hiring and payroll platform: fees for employer-of-record employment, contractor payments, payroll processing, and a growing set of adjacent products like benefits, cards, and compliance tooling. Per Notice.co, estimated revenue reached about $1.3 billion in 2025, up from roughly $800 million in 2024, with trailing-twelve-month revenue around $1.34 billion.

The growth trajectory is steep and only gently decelerating. Revenue ran from roughly $290 million in 2022 (up more than 400% as the category exploded post-pandemic) to about $470 million in 2023 (up roughly 59%), to about $800 million in 2024 (up roughly 70%), to about $1.3 billion in 2025 (up roughly 62%). Holding 60%-plus growth at a billion-dollar-plus revenue base is genuinely strong, and it is the core of the bull case.

Revenue per employee tells a useful efficiency story too. With about 9,500 employees and roughly $1.3 billion in revenue, Deel runs at around $155,000 to $164,000 of revenue per head, healthy for a business that includes a meaningful services and compliance component rather than pure software.

Why Are Investors Bullish on Deel?

The bull case starts with category leadership in a real, durable market. Global hiring and compliance is painful, fragmented, and expensive to do in-house, and Deel has become a default platform for handling it across borders. Sustained 60%-plus revenue growth at a $1.3 billion base says the land-and-expand motion is working and that customers consolidate more of their global workforce operations onto the platform over time.

The second pillar is breadth. Deel has expanded well beyond contractor payments into employer-of-record employment, full global payroll, benefits, equity and expense management, and immigration support, which deepens its hold on each customer and widens the addressable market. The more of the payroll-and-compliance stack a company runs through Deel, the harder it is to rip out.

Differentiation is the crux in a crowded HR-tech and payroll field. Our very own Hustle Fund GP, Elizabeth Yin, has made the point that in crowded markets a product needs to be 10x different and 10x better than the alternatives, not just a little cheaper or faster. Deel's argument is that owning hiring, payroll, and compliance in one global platform is meaningfully better than stitching together regional providers, and its growth suggests customers agree. But payroll and EOR have many capable competitors, so the edge has to keep compounding through product depth and global coverage.

What Are the Biggest Risks for Deel Investors?

The two biggest company-level risks are competition and regulatory complexity in a business built on navigating labor and tax law across dozens of jurisdictions. Both matter for whether growth and margins hold.

Competition and Regulatory Complexity

The competitive set is deep. Deel competes with other global EOR and payroll platforms, regional payroll incumbents, and large HR-software suites, all chasing the same expanding market. As the category matures, pricing pressure and feature parity can compress the economics that fast growth currently masks.

Regulatory complexity is structural to the business rather than incidental. Employing people across many countries means continuous exposure to changing labor laws, tax rules, worker-classification standards, and immigration regimes. A misclassification or compliance failure in a major market is not just a fine; it can dent the trust that makes enterprises willing to route their global workforce through a single vendor. The same complexity that creates Deel's moat also creates its tail risk.

The Risks Investors Underprice: The Preference Stack, Liquidity, and Information Asymmetry

For Deel specifically, the share-class question is where below-round buyers can get hurt, even though the structure here is comparatively friendly. Deel's preferred carries a 1x non-participating preference, and most preferred converts at low conversion prices set in much earlier, much cheaper rounds, which means in a strong exit nearly everyone converts to common and shares the upside. Notice.co's own waterfall shows that at an exit near the current implied value, common still comes out around $31.97 per share, close to where the stock trades, because the early preferred was issued at cents-to-low-dollars per share rather than at the $38.92 Series E price. That is a healthier picture than many down-round names. Still, the most recent Series E money sits at a $38.92 issue price with a 1x preference, so a buyer of common today is below the newest preferred in a soft outcome. Before buying, it's worth understanding liquidation preference: the term sheet clause that actually matters and where your specific shares sit.

Liquidity is a two-sided story here. Direct transfers are allowed and there is active secondary supply, which is good for buyers, but Notice.co notes demand is below supply, so the discount may persist and your own future exit could face the same imbalance. With no announced IPO, plan for liquidity events from day one and a multi-year hold.

Information asymmetry is the structural advantage every seller has over you. Private companies don't file public quarterlies, and you'd often be buying from an employee or early investor with better visibility into growth, margins, and any regulatory matters than you have. As Elizabeth has noted, valuations aren't about the "worth" of a company. They're about supply and demand among investors. Deel's below-round price is partly a demand story, more sellers than buyers right now, and a soft-demand price is not automatically a bargain.

Is Deel Overvalued at $17.3 Billion?

The more useful framing is that the market is already discounting the last round. At the $17.3 billion Series E against about $1.3 billion of revenue, Deel priced at roughly 13x revenue. The secondary market, at an implied $14.32 billion cap, is closer to 11x trailing revenue, and Notice.co's own price-to-sales figure sits near 12.9x for 2025. None of those are bubble multiples for a company still growing north of 60%.

So the question is not whether Deel is wildly overvalued; on revenue multiples it looks reasonable for the growth. The question is why the secondary trades below the primary mark and stays volatile. Possible explanations a careful buyer should weigh: secondary buyers may be pricing in deceleration risk as the base grows, regulatory or competitive overhangs, the simple supply-demand imbalance Notice flags, or share-class and rights differences between what trades on the secondary and what the Series E investors bought. The discount is a question to diligence, not an answer to assume.

On profitability, Deel has not disclosed clean margin figures in these materials, and its model blends software with lower-margin services and compliance work, which is part of why revenue-per-employee looks more like a services business than pure SaaS. The investment case rests on continued growth and operating leverage as it scales, not on a demonstrated margin profile, so a growth stumble would hit the multiple directly.

The Diligence That Actually Matters: Terms Every Buyer Should Understand

The industry myth in pre-IPO secondaries is that a price below the last primary round means you're getting a discount. Seasoned buyers know that gap often reflects share class differences, liquidation preference stacking, or transfer restrictions that materially change what you actually own. The real due diligence isn't the headline valuation; it's the cap table position, the information rights, and the legal structure of what's being transferred. Due diligence: what actually matters and what doesn't is a useful filter for where to spend your energy.

Here are the terms that determine your actual outcome:

Cap table: The company's ownership ledger showing who owns what securities. Reading it badly can make a small stake look larger than it really is.

Fully diluted ownership: Your percentage assuming all options, warrants, and convertibles become shares. Deel has a large gap between outstanding (about 445 million) and authorized (about 743 million) shares, so fully diluted math matters.

Share class: Common stock or preferred stock. This drives outcomes more than the headline valuation. The newest Series E preferred was issued at $38.92, well above where the stock trades.

Liquidation preference: The payout priority preferred holders get before common in an exit. Deel's 1x non-participating preference is relatively common-friendly, but the Series E sits ahead of common in a soft outcome.

Option pool: Shares reserved for employees and future hires. Pool refreshes are a quiet, common source of dilution, especially at a company with roughly 9,500 employees.

409A valuation: An independent valuation used for tax and option pricing. It can sit below a negotiated secondary price because the two solve different problems.

Information rights: Whether you'll get financials, updates, and visibility after you buy. Common holders often get none, which matters when growth and regulatory exposure are the whole thesis.

Pro rata rights: Whether you can participate in future rounds to defend your ownership against dilution. Most secondary buyers of common don't get these, which is why understanding anti-dilution provisions matters.

Right of first refusal (ROFR) and transfer restrictions: Deel allows direct transfers, but company consent and ROFR can still affect timing and completion. A signed agreement does not guarantee ownership until approvals clear.

Lockup: Post-IPO restrictions on selling, typically 180 days. Your liquidity event isn't the IPO; it's the lockup expiration.

If a seller or platform can't explain these clearly for the specific shares being offered, that opacity is itself a risk signal.

Eligibility and Compliance: Accredited Investor, Qualified Purchaser, and Reg D Rules

Most direct private-market offerings for individuals are limited to accredited investors, based on income, net worth, or certain credentials. Qualified purchaser status can matter when the deal is packaged through a pooled fund vehicle, and that higher threshold often determines which structures a manager can use.

Regulation D frames how most of these deals are offered. Rule 506(b) limits general solicitation and typically relies on pre-existing relationships. Rule 506(c) permits broader marketing but requires stricter verification of accredited status.

The compliance plumbing is not optional. KYC and AML checks, identity verification, source-of-funds review, FINRA-supervised broker-dealer involvement, and escrow exist because private securities carry fraud, sanctions, and suitability risks that are harder to spot when there is no public market transparency. Treat these steps as protective infrastructure, not paperwork friction.

Deal Mechanics: Direct Secondary, SPV, and the Fee Stack

A direct secondary transaction gives you ownership of the transferred shares, subject to company approval and transfer terms, and Deel permits these directly, which is a plus. An SPV gives you exposure through a pooled vehicle, which can simplify administration but adds a layer of fees, reduces direct governance, and limits your visibility into the underlying issuer. Two structures deserve extra scrutiny even when direct transfers are available:

Nested SPVs. Sometimes an SPV invests into another SPV rather than directly into the company. Each layer stacks its own management fee and carry and pushes you one step further from the cap table and any information rights. Since Deel allows direct ownership, an offer routed through multiple SPV layers deserves a hard look at why.

Forward purchase contracts. Some "access" to private shares is not share ownership at all but a contract to deliver shares or their economic value at a future event such as an IPO. That means synthetic exposure with no actual shares until settlement, plus counterparty risk: if the seller fails to deliver, you are an unsecured creditor of whoever wrote the contract, not a Deel shareholder. With a name that allows direct transfers, prefer real share ownership over a forward unless there's a clear reason.

Escrow is the bridge between signing and settlement. If ROFR is triggered or company approval stalls, your money may sit in process while the economics remain uncertain. Your all-in cost is rarely just the share price either. It can include the negotiated spread, platform fees, broker-dealer commission, legal review, admin charges, and SPV overhead, and that fee stack can erode an otherwise attractive entry. An indication of interest is not an allocation.

Where Accredited Investors May Access Deel Shares in 2026

Access usually comes through a few categories. Each has different mechanics, minimums, and information rights.

Secondary market platforms. Platforms like Forge Global, Hiive, EquityZen, and Notice list Deel, and because direct transfers are allowed and supply currently exceeds demand, buyers have real selection and negotiating room. Compare across platforms and scrutinize share class, information rights, and transfer terms.

Pre-IPO and crossover funds. Some growth and crossover funds hold Deel positions from prior rounds, offering diversified exposure in exchange for less control over the specific entry price.

Public proxies. Several of Deel's backers, including large crossover investors, are accessible through public markets, but the exposure is heavily diluted and not a clean way to express a Deel view.

Angel syndicates and investing communities. These occasionally surface SPV access to growth-stage names. This is part of why a community like Angel Squad can be useful: Hustle Fund is an early-stage fund, but it shares full-spectrum deal flow with Squad members that runs from pre-seed all the way through pre-IPO, so the same membership that teaches you to read an early-stage deal can also surface late-stage secondary opportunities when they appear.

How This Differs From Early-Stage Venture Access

Late-stage pre-IPO secondaries behave differently from early-stage venture access. Ecosystems and networks adjacent to firms like 500 Startups, accelerators like Y Combinator and Techstars, and platforms like AngelList and SeedInvest teach useful pattern recognition for evaluating founders and product-market fit. That literacy is genuinely valuable, but a $1.3 billion-revenue payroll-and-compliance secondary is a different animal: you're underwriting price, share class, growth durability, and regulatory exposure rather than a founder bet.

That said, the muscle you build evaluating early-stage deals, reading cap tables, asking sharp questions, sizing positions, is the same muscle you use for late-stage secondaries. Investors who only ever look at one stage tend to be worse at both.

Liquidity, Lockups, and Exit Paths

There are several exit paths for private-company shares, and each has different timing and return implications. An acquisition, tender offer, direct listing, conventional IPO, or extended private status can all produce very different outcomes for common shareholders. For a wider view of how public-market windows shape these exits, see the IPO market for angel investors.

Deel has not announced a firm IPO timeline, though its scale and growth make it a plausible eventual candidate when the window is open. A prior tender offer (around a $12.6 billion valuation in early 2025, per Notice.co) shows the company has facilitated liquidity before, so interim windows may recur. Buyers should still underwrite a multi-year hold and accept that the current supply-demand imbalance could shape both entry and exit pricing.

Portfolio allocation and position sizing matter more than conviction in long-duration private assets. A smart investor treats a single private secondary as one part of a broader portfolio because uncertainty around timing, competition, and regulation can overwhelm even a strong company thesis.

Bottom Line

Deel is a genuine category leader with rare growth at scale: about $1.3 billion in revenue, still compounding north of 60%, in a market enterprises can't easily handle themselves. On revenue multiples, the secondary price looks reasonable rather than frothy, and a comparatively common-friendly preference structure means buyers of common are not as exposed as in many below-round names.

The catch is the discount itself. Secondary shares trade below the last round with more sellers than buyers, the price has been volatile, and the business carries real competitive and regulatory tail risk. Whether it's a good investment depends far less on whether Deel is a good company and far more on the share class you buy, the price you pay against the waterfall, and your read on why the market is discounting a fast-growing leader.

The investors who do best in private markets stay allergic to hype, read the documents, and remember that structure often matters as much as story. With Deel, the story is strong, so the discount and the terms are exactly where your diligence should focus.

Frequently Asked Questions

Is Deel publicly traded? No. Deel is a private company and does not trade on any public exchange. There is no Deel ticker symbol. Because Deel allows direct stock transfers, accredited investors can access shares through secondary platforms like Forge Global, Hiive, EquityZen, and Notice, or through angel investing communities that occasionally surface SPV access.

What is Deel's current valuation? Deel's last primary valuation is $17.3 billion, set in its October 2025 Series E. As of mid-2026, secondary marks imply a lower figure, around $14.3 billion per Notice.co, roughly a 17% discount to the last round.

Who owns Deel? Deel was founded in 2017 by CEO Alex Bouaziz and Shuo Wang. Notable investors include Andreessen Horowitz, Coatue, Spark Capital, General Catalyst, Green Bay Ventures, and others across its eight rounds.

Is Deel profitable? Deel has not disclosed clean profitability figures in these materials. Its model blends software with lower-margin services and compliance work, so the investment case rests on continued growth and operating leverage at scale rather than a demonstrated margin profile.

Why does Deel trade below its last round? The $17.3 billion mark was set in the October 2025 Series E at $38.92 per share, while the secondary trades closer to $32. Possible reasons include deceleration risk as the base grows, competitive and regulatory overhangs, and a current supply-demand imbalance with more sellers than buyers. The discount is a question to diligence, not a guaranteed bargain.

How can accredited investors buy Deel stock? Through secondary platforms (direct transfers are allowed), crossover funds with prior-round positions, and angel communities that source SPV access. Each path has different minimums, fees, compliance steps, and information rights, and sophisticated buyers verify share class, transfer restrictions, ROFR language, and the exit waterfall before transacting.